ARYS-0701 Site 12 — Raleigh, North Carolina

ARYS-0701 Site 12 is a clinical research site located in Raleigh, North Carolina, United States 27612.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

ARYS-0701 Site 12 has participated in 1 clinical trials.

Therapeutic areas: Herpes Zoster, Postherpetic Neuralgia.

Sponsors: aRigen Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ARYS-0701 Site 12?

ARYS-0701 Site 12 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ARYS-0701 Site 12 conducted?

ARYS-0701 Site 12 has 1 clinical trials on record. Their work covers Herpes Zoster, Postherpetic Neuralgia.

Is ARYS-0701 Site 12 accredited by Crixeo Health?

ARYS-0701 Site 12 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ARYS-0701 Site 12?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.